Načítá se...
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity
BACKGROUND: Based on its role in angiogenesis and apoptosis, the inhibition of NFκB activity is considered an effective treatment for cancer, hampered by the lack of selective and safe inhibitors. We recently demonstrated that the RH domain of GRK5 (GRK5-RH) inhibits NFκB, thus we evaluated its effe...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2780391/ https://ncbi.nlm.nih.gov/pubmed/19900276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-8-97 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|